Michael Cho

Wave Biotech LLC develops and manufactures process equipment for the pharmaceutical and biotechnology industry. The company was founded in 1998 by Vijay Singh and is headquartered in Somerset, NJ

RoosterBio, Inc. provides standardized stem cell platforms that enable clinical and commercial translation. Its products include bioprocess media, plug and play systems, clinical control, and roosterbio swag products. The company was founded Jon A. Rowley in 2013 and is headquartered in Frederick, MD.

AGC Biologics A/S provides contract process development and biopharmaceuticals manufacturing services worldwide. It specializes in delivering custom solutions for the scale-up and the cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials, and commercial production. Its services include cell line development, bioprocess development, formulation, and analytical testing. The company was founded by Peter Vilby, Mads Laustsen, Thomas Sandal, and Morten Munk in 2001 and is headquartered in Soeborg, Denmark.

AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA.

Part of Bayer AG, Bayer HealthCare is a company that provides medical care and animal health care services. The company is based in Tarrytown, NY.

FloDesign Sonics, Inc. provides acoustic technology for separations and filtrations. It develops technology that sound vibrations to filter fluids including blood. The firm also develops filter-less acoustophoretic separation technology, and separate multiple types of particles of varying sizes including water and oil, blood cells, CHO cells, emulsified oils, algae, metals, and bacteria. The company was founded by Bart Lipkens, Stanley Kowalski III, Walter Presz and Louis Masi in 2009 and is headquartered in Wilbraham, MA.

Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium.

Dynamk Capital LLC (Dynamk Capital) is a venture capital firm founded in 2017 by Daniella Kranjac and Mario Kranjac. The firm is headquartered in New York, New York.

Alpenglow Biosciences, Inc. engages in the development and production of three-dimensional open-top light-sheet microscope for the improvement of conducting pathology. The company was founded by Steven Buckley, Adam Glaser, Jonathan Liu, Nicholas Reder, and Larry True in 2018 and is headquartered in Seattle, WA.

CellFE, Inc. develops delivery platform to enable engineering of life-saving therapies. The company was founded by Anna Liu and Alla Zamarayeva in 2018 and is headquartered in San Carlos, CA.

Lucid Scientific, Inc. provides technology services. The company is headquartered in Atlanta, GA.

Vernal Biosciences, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that specializes in manufacturing and formulating mRNA and LNP-mRNA. Vernal's focus is on democratizing access to their expertise and unparalleled LNP-platform technologies to accelerate the potential of mRNA. The American company provides comprehensive high purity platform manufacturing solutions for mRNA-based medicines, from research to clinical development. Vernal Biosciences is pioneering the custom development and manufacturing process for a variety of applications including vaccine development, gene replacement, and more. The company was founded in 2021 and is headquartered just outside of an undisclosed location. The company was founded by Cobaugh Christian, who has been the CEO since incorporation.

Virica Biotech, Inc. is a Canadian company that specializes in viral medicines, including gene therapies, vaccines, and oncolytic viruses. The company is based in Ottawa, Canada and was founded in 2018 by Ella Korets-Smith and Jean-Simon Diallo. The company has developed a new product category of viral sensitizers (VSE™) that removes the barriers to manufacturing effective viral medicines at scale. The company's purpose is to realize the promise of viral medicines and extend the horizons of human healthcare. Jean-Simon Diallo has been the CEO since 2018.

Part of Ncardia SA, Cellistic is a subsidiary that specializes in the process development and manufacture of cell therapies based on human induced pluripotent stem cell (iPSC) technology. The Belgian company's focus and expertise in iPSC reprogramming, differentiation, and expansion protocol development make it an ideal partner for innovative cell therapy developers to commercialize novel advanced therapies. The company was founded by Stefan Braam, and Gustavo Mahler has been the CEO of the company since 2023.